The Novo Nordisk Foundation has, through its 2024 Challenge Programme, invested 120 million Danish kroner in two research projects that address significant challenges within energy production based on nuclear processes.
One project aims to pave the way for the continuous operation of fusion power plants, while the other project is based on research into molten salts for advanced reactor technology and energy.